Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Dose-response relationship assessment

If possible, there should be measurement of the toxic effect in order quantitatively to relate the observations made to the degree of exposure (exposure dose). Ideally, there is a need to determine quantitatively the toxic response to several differing exposure doses, in order to determine the relationship, if any, between exposure dose and the nature and magnitude of any effect. Such dose—response relationship studies are of considerable value in determining whether an effect is causally related to the exposure material, in assessing the possible practical (in-use) relevance of the exposure conditions, and to allow the most reasonable estimates of hazard. [Pg.226]

Dose—response relationships are useful for many purposes in particular, the following if a positive dose—response relationship exists, then this is good evidence that exposure to the material under test is causally related to the response the quantitative information obtained gives an indication of the spread of sensitivity of the population at risk, and hence influences ha2ard evaluation the data may allow assessments of no effects and minimum effects doses, and hence may be valuable in assessing ha2ard and by appropriate considerations of the dose—response data, it is possible to make quantitative comparisons and contrasts between materials or between species. [Pg.232]

Hazard characterization and delineation of dose-effect or dose-response relationships. 3. Assessment of exposure 4. Risk characterization... [Pg.328]

Dose-response assessment is the process of obtaining quantitative information about the probability of human illness following exposure to a hazard it is the translation of exposure into harm. Dose-response curves have been determined for some hazards. The curves show the relationship of dose exposure and the probabihty of a response. Since vahdated dose-response relationships are scarce, various other inputs are used to underpin the hazard characterization phase of risk assessment. [Pg.570]

Decision Analysis. An alternative to making assumptions that select single estimates and suppress uncertainties is to use decision analysis methods, which make the uncertainties explicit in risk assessment and risk evaluation. Judgmental probabilities can be used to characterize uncertainties in the dose response relationship, the extent of human exposure, and the economic costs associated with control policies. Decision analysis provides a conceptual framework to separate the questions of information, what will happen as a consequence of control policy choice, from value judgments on how much conservatism is appropriate in decisions involving human health. [Pg.186]

Most immunotoxic responses express a clear dose-response relationship that can be used for human risk assessment. However, it is more difficult to extrapolate in vitro concentrations than in vivo animal doses (plasma concentrations) to the clinical dose. [Pg.583]

Therapeutic confirmatory (Phase III) Demonstrate/confirm efficacy Establish safety profile Provide an adequate basis for assessing the benefit/risk relationship to support licensing Establish dose-response relationship Adequate and well controlled studies to establish efficacy Randomized parallel dose-response studies Clinical safety studies Studies of mortality/morbidity outcomes Large simple trials Comparative studies... [Pg.781]

Dose-response relationships figure prominently in the development of risk assessments, and we shall have much to say about them. [Pg.75]

The critical question of dose-response relationships is given only cursory mention in this chapter. Keep in mind that all of the toxic phenomena described in this chapter and those on carcinogens exhibit such relationships we return to the dose-response issue in the chapters on risk assessment. [Pg.104]

Dose-response relationships for two animal carcinogens, strikingly different in potency, are presented in Tables 6.2 and 6.3. The type of information presented in the tables is the usual starting point for risk assessments as we shall see, human exposures to these carcinogens are very much less than the NOAELs and LOAELs from the animal data. [Pg.190]

As has been emphasized so many times in the preceding chapters, these various manifestations of toxicity all display dose-response characteristics, where by response we refer to the incidence or severity of specific adverse health effects. As we demonstrated in earlier chapters, toxic responses increase in incidence, in severity, and sometimes in both, as dose increases. Moreover, just below the range of doses over which adverse effects can be observed, there is usually evidence for a threshold dose, what we have called the no-observed adverse effect level (NOAEL). The threshold dose must be exceeded before adverse effects become observable (Chapter 3). Deriving from the literature on toxic hazards, descriptions of the dose-response relationships for those hazards comprise the dose-response assessment step of the four-step process. [Pg.207]

Pharmacokinetics has played a crucial and somewhat unusual role in the assessment of health risks from methylmercury. Some of the epidemiology studies of this fish contaminant involved the measurement of mercury levels in the hair of pregnant women, and subsequent measurements of health outcomes in their offspring (Chapter 4). Various sets of pharmacokinetic data allowed estimation of the level of methylmercury intake through fish consumption (its only source) that gave rise to the measured levels in hair. In this way it was possible to identify the dose-response relationship in terms of intake, not hair level. Once the dose-response relationship was established in this way, the EPA was able to follow its usual procedure for establishing an RfD (which is 0.1 ag/(kg b.w. day)). [Pg.255]

And there are significant questions (as yet unanswered) regarding methods for assessing risks. Perhaps, for example, traditional notions of dose-response relationships are inapplicable when the particle size, or perhaps the surface area (huge relative to mass) is the real risk determinant. There is much to be done, and those promoting these exciting new products should no doubt be equally determined to promote the development of the information needed for reliably assessing their health and environmental risks. [Pg.269]

Related terms Effect Assessment, Dose-Response Relationship. [Pg.4]

Related terms Hazard Characterization, Dose-Effect Relationship, Effect Assessment, Dose—Response Relationship, Concentration—Effect Relationship. [Pg.5]

Related terms Dose-Ejfect Relationship, Effect Assessment, Dose-Response Relationship, Concentration-Effect Relationship. [Pg.6]


See other pages where Dose-response relationship assessment is mentioned: [Pg.110]    [Pg.226]    [Pg.19]    [Pg.326]    [Pg.237]    [Pg.190]    [Pg.190]    [Pg.11]    [Pg.121]    [Pg.247]    [Pg.303]    [Pg.63]    [Pg.270]    [Pg.1394]    [Pg.308]    [Pg.595]    [Pg.287]    [Pg.808]    [Pg.19]    [Pg.185]    [Pg.186]    [Pg.187]    [Pg.189]    [Pg.82]    [Pg.161]    [Pg.357]    [Pg.582]    [Pg.25]    [Pg.75]    [Pg.223]    [Pg.243]    [Pg.264]    [Pg.179]    [Pg.42]   
See also in sourсe #XX -- [ Pg.28 ]




SEARCH



Cancer risk assessment dose-response relationships

Dose assessment

Dose relationships

Dose response assessment structure-activity relationship

Dose-response assessment

Dose-response assessment responses

Dose-response relationship

Dose-response relationship exposure assessment

Dose-response relationships risk assessment

Hazard assessment dose-response relationships

Response Relationship

© 2024 chempedia.info